drugset / Trial / NCT01786824

Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration

NCT01786824

Phase 3 Terminated 9 enrolled Nîmes University Hospital
RandomizedFactorialOpen-labelPrevention

Summary

The general objective of this open, pilot study is to characterize biological parameters related to acute kidney injury among patients undergoing a programmed coronarography with injection of contrast material. The study focuses on two main factors that may influence acute kidney injury: (1) sodium chloride hydration strategy versus sodium bicarbonate hydration strategy and (2) presence of oral L-carnitine treatment versus absence of oral L-carnitine treatment. We will also test for a potential interaction between these two factors.

Timeline

Start
2014-12
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 3 g Oral
Subject sodium bicarbonate Diagnostic / imaging agent 1.4 % Intravenous
Subject sodium bicarbonate Diagnostic / imaging agent 500 ml Intravenous
Subject sodium chloride Unknown 0.9 % Intravenous